Low NT5DC2 expression predicts favorable prognosis and suppresses soft tissue sarcoma progression via ECM-receptor interaction pathway

CONCLUSION: Low expression of NT5DC2 predicts a favorable prognosis in soft tissue sarcoma, and downregulated NT5DC2 expression can suppress sarcoma cell progression through the ECM-receptor interaction pathway.PMID:38547613 | DOI:10.1016/j.tranon.2024.101937
Source: Translational Oncology - Category: Cancer & Oncology Authors: Source Type: research